Halozyme Therapeutics News, Halozyme Therapeutics Quote, HALO Quote

Halozyme Therapeutics (NQ:HALO) Delayed: 74.96 +2.32 (3.19%)

Prev. Close

$72.64

Today 6M 1Y 5Y

Open

$72.96

52 Wk High

$18.39

52 Wk Low

$6.96

Day High

$76.32

Day Low

$72.71

P/E

N/A

EPS

$-0.58

Volume

2,872,443

Friends, Peers and Foes (?): MRK, BMY, MRUS, ABBV, AMGN (more...)

ALERTS | RSS

Jun 16, 2026 06:43 AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Jun 15, 2026 04:10 PM Form 4 HALOZYME THERAPEUTICS, For: Jun 12 Filed by: Snyder Mark Howard
Jun 15, 2026 06:01 AM Halozyme expects minimal Medicare pricing impact on royalties through 2035
Jun 15, 2026 06:00 AM Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
Jun 9, 2026 04:59 PM Form 3 HALOZYME THERAPEUTICS, For: Jun 08 Filed by: Snellgrove Darren
Jun 3, 2026 08:07 PM Form 4 HALOZYME THERAPEUTICS, For: Jun 01 Filed by: Torley Helen
Jun 3, 2026 09:02 AM Benchmark Reiterates Buy Rating on Halozyme Therapeutics (HALO) on Near-Term Potential
Jun 2, 2026 05:20 PM Form 4 HALOZYME THERAPEUTICS, For: Jun 01 Filed by: Connaughton Bernadette
May 20, 2026 04:31 AM JPMorgan Reinstates Halozyme Therapeutics (HALO) at Neutral
May 15, 2026 04:19 PM Form 144 HALOZYME THERAPEUTICS, Filed by: LaBrosse Nicole

Entities mentioned with HALO

View All Entities